Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Sell ContextLogic Stock While You Can Before Paper Losses Worsen

By Chris Lau, InvestorPlace Contributor

Investors WISH they did not invest in the company as its outlook, setting the risk for a lower stock price ahead.

Avoid Lucid Motors Stock Until the Post-Merger Dust Settles

By Chris Lau, InvestorPlace Contributor

LCID stock successfully completed its merger with the CCIV SPAC despite some bumps along the road, but don't jump in immediately.

For Now, Fisker Stock Is at the Mercy of the Market

By Chris Lau, InvestorPlace Contributor

Fisker shares are on sale again as the momentum investors dump electric vehicle stocks, giving patient investors an entry point.

7 Dividend Stocks To Buy as Treasury Yields Tumble

By Chris Lau, InvestorPlace Contributor

Investors want high-quality growth stocks offering high dividend yields, as the safer Treasury yields tumble. Here are seven names to consider.

Coupang Stock Has Real Breakout Potential as the Company Expands in Asia

By Chris Lau, InvestorPlace Contributor

CPNG stock is ready to break out if its trial openings in Taiwan and Japan are successful, paving the way to a bigger addressable market.

Load More